Mirza Ismail Baig: Silent but Significant – The Clinical Importance of Pulmonary Embolism
Mirza Ismail Baig, Clinical Intern and Physician Assistant at CARE Hospitals, Quality CARE India Limited, shared a post on LinkedIn:
“Silent but Significant: The Clinical Importance of Pulmonary Embolism
Pulmonary embolism (PE) remains one of the most potentially fatal yet frequently underrecognized cardiovascular emergencies.
The condition occurs when a thrombus, most commonly originating from the deep veins of the lower extremities, embolizes to the pulmonary circulation and obstructs blood flow.
Common risk factors include:
- Prolonged immobilization
- Recent surgery
- Malignancy
- Pregnancy and postpartum state
- Previous venous thromboembolism
- Inherited thrombophilia
Clinical presentation can vary widely, ranging from mild dyspnea to sudden hemodynamic collapse.
Key findings may include:
- Acute onset shortness of breath
- Pleuritic chest pain
- Tachycardia
- Hypoxemia
- Syncope in severe cases
One of the most important lessons in clinical medicine is that a normal chest X-ray does not exclude a life-threatening diagnosis.
Diagnostic evaluation often relies on:
- D-dimer testing
- CT Pulmonary Angiography (CTPA)
- Echocardiography in unstable patients
- Clinical prediction tools such as the Wells Score
Early anticoagulation with agents such as:
- Enoxaparin
- Unfractionated Heparin
- Apixaban
- Rivaroxaban
can significantly improve outcomes when initiated promptly.
Pulmonary embolism serves as a reminder that not every patient with acute breathlessness has a primary respiratory disease—sometimes the pathology lies within the pulmonary vasculature itself.”
Stay updated with Hemostasis Today.
-
Jun 6, 2026, 08:25Marina Tarunina: Engineered Platelets From Human iPSCs Support Haemostasis Without Thromboembolism
-
Jun 6, 2026, 08:21Razieh Parizad: Systematic Review Evaluates the Future Role of Factor XI Inhibitors in Stroke Prevention
-
Jun 6, 2026, 08:10Vrinda Trivedi: Hematologic Emergencies and Anticoagulation Strategies Spotlighted at CCCES 2026
-
Jun 6, 2026, 08:02Krisstina Gowin: Could the Gut Microbiome Be the Missing Link in Hematology Outcomes?
-
Jun 6, 2026, 07:59Razan Awan: Large Cohort Study Questions Routine Use of Dual Antiplatelet Therapy After TAVI
-
Jun 6, 2026, 07:28Ahmed Dheyaa Al-Obaidi: Retrospective Study Highlights the Role of Transient Elastography in Pediatric Hepatic Fibrosis
-
Jun 6, 2026, 06:55Valeria Galetti: Understanding the Root Causes of Anemia in Madagascar
-
Jun 6, 2026, 06:45Abdulrahman Al-Mashdali: Emerging Role of Anti-CD38 Therapy in ITP
-
Jun 6, 2026, 06:20Pedro Gaspar: The Role of CD4⁺ T Cells in APS